S&P 500   4,396.79 (-1.04%)
DOW   34,625.48 (-0.70%)
QQQ   363.95 (-1.73%)
AAPL   144.08 (-0.89%)
MSFT   287.96 (-2.11%)
FB   343.80 (-2.77%)
GOOGL   2,750.70 (-2.51%)
TSLA   783.95 (-0.94%)
AMZN   3,339.15 (-1.96%)
NVDA   210.12 (-2.99%)
BABA   150.99 (+0.54%)
NIO   35.77 (-2.72%)
CGC   14.63 (-0.54%)
GE   105.44 (+0.09%)
MU   73.54 (-2.18%)
AMD   105.48 (-2.48%)
T   27.44 (+0.15%)
F   14.54 (+2.68%)
ACB   6.60 (+3.29%)
DIS   176.10 (-1.21%)
PFE   42.71 (-1.97%)
BA   221.81 (-1.05%)
AMC   37.87 (-3.64%)
S&P 500   4,396.79 (-1.04%)
DOW   34,625.48 (-0.70%)
QQQ   363.95 (-1.73%)
AAPL   144.08 (-0.89%)
MSFT   287.96 (-2.11%)
FB   343.80 (-2.77%)
GOOGL   2,750.70 (-2.51%)
TSLA   783.95 (-0.94%)
AMZN   3,339.15 (-1.96%)
NVDA   210.12 (-2.99%)
BABA   150.99 (+0.54%)
NIO   35.77 (-2.72%)
CGC   14.63 (-0.54%)
GE   105.44 (+0.09%)
MU   73.54 (-2.18%)
AMD   105.48 (-2.48%)
T   27.44 (+0.15%)
F   14.54 (+2.68%)
ACB   6.60 (+3.29%)
DIS   176.10 (-1.21%)
PFE   42.71 (-1.97%)
BA   221.81 (-1.05%)
AMC   37.87 (-3.64%)
S&P 500   4,396.79 (-1.04%)
DOW   34,625.48 (-0.70%)
QQQ   363.95 (-1.73%)
AAPL   144.08 (-0.89%)
MSFT   287.96 (-2.11%)
FB   343.80 (-2.77%)
GOOGL   2,750.70 (-2.51%)
TSLA   783.95 (-0.94%)
AMZN   3,339.15 (-1.96%)
NVDA   210.12 (-2.99%)
BABA   150.99 (+0.54%)
NIO   35.77 (-2.72%)
CGC   14.63 (-0.54%)
GE   105.44 (+0.09%)
MU   73.54 (-2.18%)
AMD   105.48 (-2.48%)
T   27.44 (+0.15%)
F   14.54 (+2.68%)
ACB   6.60 (+3.29%)
DIS   176.10 (-1.21%)
PFE   42.71 (-1.97%)
BA   221.81 (-1.05%)
AMC   37.87 (-3.64%)
S&P 500   4,396.79 (-1.04%)
DOW   34,625.48 (-0.70%)
QQQ   363.95 (-1.73%)
AAPL   144.08 (-0.89%)
MSFT   287.96 (-2.11%)
FB   343.80 (-2.77%)
GOOGL   2,750.70 (-2.51%)
TSLA   783.95 (-0.94%)
AMZN   3,339.15 (-1.96%)
NVDA   210.12 (-2.99%)
BABA   150.99 (+0.54%)
NIO   35.77 (-2.72%)
CGC   14.63 (-0.54%)
GE   105.44 (+0.09%)
MU   73.54 (-2.18%)
AMD   105.48 (-2.48%)
T   27.44 (+0.15%)
F   14.54 (+2.68%)
ACB   6.60 (+3.29%)
DIS   176.10 (-1.21%)
PFE   42.71 (-1.97%)
BA   221.81 (-1.05%)
AMC   37.87 (-3.64%)
CNSX:CSI

Chemesis International Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume63,715 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive CSI News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemesis International and its competitors with MarketBeat's FREE daily newsletter.


About Chemesis International

Chemesis International Inc., together with its subsidiaries, cultivates, manufactures, distributes, and retails cannabis products in California, Puerto Rico, and Colombia. It offers various types of extractions, formulations, and products specializing in BHO extraction, alcohol extraction, and CO2 extraction. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers—Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Chemesis International (CNSX:CSI) Frequently Asked Questions

What stocks does MarketBeat like better than Chemesis International?

Wall Street analysts have given Chemesis International a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Chemesis International wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Chemesis International's key executives?

Chemesis International's management team includes the following people:
  • Mr. Josh Rosenberg, Pres & Director
  • Mr. Eli Seamus-Sweet Dusenbury C.A., CPA, CPA, CA, Chief Financial Officer (Age 38, Pay $104.48k)
  • Mr. Terry White, Sr. VP of Operations
  • Dr. Joshua Hartsel, Chief Science Officer
  • Ms. Vinnie Pappano, VP of Sales & Category Management of CBD
  • Mr. Thomas J. Gingerich, Controller (Age 60)

What is Chemesis International's stock symbol?

Chemesis International trades on the CNSX under the ticker symbol "CSI."

How do I buy shares of Chemesis International?

Shares of CSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How many employees does Chemesis International have?

Chemesis International employs 147,000 workers across the globe.

What is Chemesis International's official website?

The official website for Chemesis International is www.chemesis.com.

How can I contact Chemesis International?

The company can be reached via phone at 604-398-3378.


This page was last updated on 9/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.